
CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia ...
Two studies track changes in cutaneous phosphorylated alpha-synuclein (P-SYN) in patients with dementia with Lewy bodies (DLB); the other determines the optimal number of skin biopsies necessary for accurate detection of P-SYN SCOTTSDALE, Ariz., March 27, …